Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. March 22, 2018. Katarzyna Mazur-Hofsäss.

Executive Summary

The head of Zimmer Biomet's EMEA division, Katarzyna Mazur-Hofsäss, is concerned about how the EU's new Medical Device and IVD Regulations will affect the market there. Check out what she said here.

"Europe used to have an advantage [over other geographies] in that the path to market here for innovation was faster, without there having been any – in my strong opinion – negative impact on patient safety. But this is changing with the new regulations. This advantage is disappearing and, together with the lower pricing and much more fragmented nature of the market, it makes Europe that little bit less attractive, and it matters." –Katarzyna Mazur-Hofsäss, EMEA president, Zimmer Biomet

Click here for a free trial of Medtech Insight


Related Content

Exec Chat: Zimmer Biomet's EMEA Head On Facing The New Reality In Health Care





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts